<DOC>
	<DOCNO>NCT01142726</DOCNO>
	<brief_summary>The primary purpose protocol demonstrate ability abatacept plus methotrexate induce remission patient early rheumatoid arthritis 12 month treatment maintain remission follow 6 month drug withdrawal .</brief_summary>
	<brief_title>Efficacy Safety Study Abatacept Subcutaneous Plus Methotrexate Inducing Remission Adults With Very Early Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Key Presence active clinical synovitis least 2 joint , 1 must small joint , minimum 8 week prior screen Onset persistent symptom ≤ 2 year prior screen Positive test result anticyclic citrullinated peptide 2 Methotrexate naive minimum exposure methotrexate , define 10 mg/week ≤4 week methotrexate dose 1 month prior screen visit Biologic naive , include treatment investigational biologic prior screen Disease Activity Score 28 base Creactive protein score ≥3.2 screen Withdrawal treatment chloroquine , hydroxychloroquine , and/or sulfasalazine ( washout ) minimum 28 day prior randomization If receive oral corticosteroid , stable low dose ( ≤ 10 mg/day prednisone equivalent ) least 4 week Able undergo magnetic resonance image Key Meeting diagnostic criterion rheumatic disease ( eg , lupus erythematosus ) Treatment intravenous , intramuscular , intraarticular corticosteroid within 4 week prior randomization Scheduled anticipate joint replacement surgery Presence concomitant illness likely require systemic glucocorticosteroid therapy study , opinion investigator History malignancy last 5 year Any serious bacterial infection within last 3 month treat resolve antibiotic , chronic recurrent bacterial infection At risk tuberculosis Evidence active latent bacterial viral infection time potential enrollment , include human immunodeficiency herpes zoster virus cytomegalovirus resolve less 2 month prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>